Healthcare marketing, decoded from the trade floor.
The MM+M Podcast is a trade-focused look at medical marketing, pharma media, agency relationships, and healthcare brand strategy. It favors practical interviews and news-driven context over broad business chatter, often asking how industry shifts change the work of reaching patients, HCPs, and prescribers.
PRESS PLAY
The MM+M Podcast covers healthcare marketing from inside the trade, with episodes that treat pharma communications, medical media, agency strategy, and brand behavior as connected parts of the same market. It is not a general health show. Its center of gravity is the work of persuading, informing, measuring, and reaching audiences in a regulated, crowded, and politically sensitive sector. The conversations often start from concrete developments. A new HealthFront conference lineup becomes a way to talk about sports, celebrity, media marketplaces, and healthcare sponsorships. A study of 150 physicians becomes a discussion of AI, search, trust, and how clinical information needs to be structured for both people and machines. A Weight Watchers episode turns GLP-1 disruption into a brand-repositioning story, with bankruptcy, telehealth competitors, and long-term support all part of the frame. The show also spends time with agency leaders and platform builders. Those episodes examine how healthcare brands make campaigns memorable, how AOR relationships can become less transactional, and how programmatic tools use first-party HCP data, AI agents, and efficiency claims to serve medical marketers. The tone is mostly measured. It can be amused, especially around sports analogies or recurring policy turbulence, but it rarely drifts into loose banter for long. The questions tend to set the scene before narrowing toward a trade problem: what friction needs to be removed, what evidence needs to become usable, what audience behavior has changed, and what marketers should do next. That makes the show useful for listeners who already know the acronyms and want to hear how practitioners are interpreting the next turn. It also captures the odd texture of modern pharma marketing, where a Barry Sanders cardiovascular campaign, an oral GLP-1 battle, a physician AI workflow, and a conference preview can all belong to the same editorial map.
Made for: The show suits healthcare marketers, pharma brand teams, agency leaders, medical media buyers, and industry observers who want practical context around campaigns, channels, policy pressure, and HCP behavior.
What sets it apart: Its strength is the trade-publication lens: episodes use current healthcare marketing events as entry points, then push guests toward operational detail about media, evidence, audience behavior, and brand execution.
MM+M editors Jameson Fleming, Jack O'Brien, Bella Czajkowski, Lecia Bushak, and Steve Madden speak with people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes released each week.
Based on 6 episodes we listened to · September 2026
The MM+M Podcast makes healthcare marketing legible through practical conversations about media strategy, patient communication, advertising technology, and shifting drug markets.
The MM+M Podcast treats healthcare marketing as an operating business, following the decisions behind media spending, patient communication, brand reputation, and drug-market shifts.
Weight-loss drugs meet Super Bowl ads, giving you the healthcare marketer's view from backstage.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A clear pulse check on how healthcare marketing is borrowing from sports, creators, and broader media.
Andrea Palmer's return makes Healthfront feel less like an agency victory lap and more like a useful read on where healthcare marketing is borrowing ideas, especially from sports, creator partnerships, and the wider media market.
Clinical evidence matters most when it becomes usable understanding under pressure.
Jack O'Brien's conversation with Danielle Cranwell and Keith Testa makes a plain point: evidence only matters if people can use it when the pressure is on.
A practical map of where physicians trust AI, where they do not, and why that matters.
This episode gives a clear look at how 150 U.S.-based physicians across 12 specialties look for, judge, and use clinical information in a digital mess that keeps getting harder to navigate.
A healthcare marketing episode that links programmatic buying with the GLP-1 oral pill race.
This episode gives HaloArch the room it needs without turning the whole thing into a launch puff piece. Steve Madden and Louis Naimoli walk through what the product is, how Haymarket's first-party HCP data from its 30-plus medical publications shapes the pitch, and why the AI…
Weight Watchers' GLP-1 reset feels less like a comeback than a test of relevance.
The episode treats Weight Watchers as a company trying to find its footing after GLP-1s rewrote the market around it. It does not lean on nostalgia; it keeps the focus on strategy, pressure, and what the business has to answer next.
A Super Bowl-flavored lead-in that lands on MMM's 40 Under 40 honoree.
MMM uses a Super Bowl aftermath conversation to point toward something sturdier: its 2026 live events and this year's 40 Under 40 dinner in Midtown Manhattan.
A grounded look at Reddit, healthcare messaging, and the balance between trust and moderation.
The MM+M Media Summit keynote treats Reddit as a practical case study for healthcare marketing, with a clear look at how brands reach patients, HCPs, and caregivers through timely, relevant, engaging content.
A practical preview of how AI is reshaping brand reputation, especially in healthcare.
Haymarket Media's AI Deciphered preview focuses on the pressure points AI is putting on copyright, creativity, ethics, and brand reputation, with healthcare treated as a particularly important example.
Sharper words for business builders.
Paid social updates with account-level judgment.
Creator economy strategy, without the buzzword fog.
Jack O'Brien opens the MM&M Podcast by framing the episode around “when knowing isn’t doing” and the problem of turning clinical evidence into real-world action.
HealthFront is back.
AI can help, but physicians still care where the answer came from.
VCCP Health's head of account management Chris Brandau introduces the CHESS framework — character, humor, emotion, surprise, and sonic branding — as five behavioral-science-backed levers for making healthcare and pharma advertising more memorable.
A rocket launch opens the door.
Weight Watchers is trying to find its footing again.
This episode explores how to transform client-AOR relationships from transactional to strategic partnerships in pharma marketing, featuring leaders from Woven Health Collective.
This episode features an interview with Pro Football Hall of Famer Barry Sanders about his partnership with Amgen to raise awareness about cardiovascular disease and bad cholesterol, plus a preview of the 2026 MM+M Transform Conference.
Host Steve Madden interviews Dave Paragamian, CEO of Health Monitor Network, about his career journey and lessons from Procter & Gamble, as part of MM+M's 60th anniversary series on industry diamonds.
Jack O'Brien interviews Justin Fried about AI and emerging technologies reshaping healthcare marketing and patient engagement.
The episode welcomes a new reporter and discusses the end of Vinay Prasad's tenure at the FDA.
This episode discusses potential AI regulations in healthcare marketing, focusing on digital avatars, and includes a segment on a Bayer lawsuit and a satirical FDA letter.
The episode discusses AbbVie's new podcast The Persistence Lab and trends in AI and healthcare.
The episode celebrates MM&M's 60th anniversary with the founder's grandson, discussing the brand's history and current FDA warning letter trends.
The Patriots lost 29 to 13, and that quick football detour gets MM+M into its preview of the 2026 40 Under 40 ceremony.
Discussion of a Super Bowl ad for the weight loss drug Gobi, featuring DJ Khaled and a marketing executive, focusing on destigmatizing weight loss and the drug's health benefits.
The episode discusses pharma brands advertising during the Super Bowl and features an interview with leaders from Avalere Health about navigating regulatory challenges.
The episode covers the killing of a nurse by federal agents and then discusses upcoming initiatives for Rare Disease Month and industry awards.
The episode features an interview with actors Justin Long and John Hodgman about their roles in Novo Nordisk's new Ozempic advertising campaign.
Interview with Matt McNally about his return to Publicis Health and the state of healthcare marketing.
The episode covers CES 2025 highlights, AI's role in healthcare, and medical marketing industry resolutions for 2026.
The MM+M Podcast editorial team reviews major events in healthcare marketing in 2025, including RFK Jr.'s HHS tenure and AI's impact, and previews 2026.
This episode features an interview with Katie Chilotta, a GLP-1 evangelist, discussing the future of GLP-1 drugs, including market expansion, new applications, and challenges in access and communication.
A discussion on responsible AI adoption in pharmaceutical medical communications, emphasizing governance and human oversight.
Interview with Arcutis CEO about a skincare campaign featuring Tori Spelling and the company's growth strategy.
An interview discussing AI-powered audience intelligence in healthcare marketing, focusing on data strategy and LLM optimization.
This episode examines how the killing of UnitedHealthcare CEO Brian Thompson one year ago has transformed health brands' communication strategies and sparked public debate about healthcare costs and access.
This episode features an interview with Justin Thomas-Copeland, CEO of the 4A's, discussing how digital marketing can transform healthcare brands based on his extensive experience in both agency and pharmaceutical roles.
This episode covers interviews from the AI Deciphered conference on AI's impact on pharma reputation and marketing, plus a discussion on patient centricity.
This episode explores how AI and GLP-1 weight loss drugs are reshaping medical marketing, featuring an interview with a healthcare-tech leader and updates on recent developments in the GLP-1 sector.
Reddit gets the keynote treatment, then the audience takes over.
AI Deciphered gets a grounded preview.
Discussion of healthcare marketing trends, award-winning campaigns, and the role of AI in the industry.
A discussion about private equity's growing role in healthcare marketing, featuring guests from Supreme Group and Pivot Design.
The episode features an exit interview with a summer intern and discusses pharma Q2 earnings season.